Citius Pharma (CTXR.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Aug13

Citius Pharma released FY2025 9 Months Earnings on August 12, 2025 (EST), with actual revenue USD 0 and EPS USD -3.3744

03:00

Citius Pharma released FY2025 Q3 earnings on August 12 (EST), actual revenue USD 0 (forecast USD 1.919 M), actual EPS USD -0.8 (forecast USD -0.21)

03:00

Aug8

Citius Pharmaceuticals Inc to report a loss of 59 cents per share

12:38

Jul11

Citius Pharmaceuticals, Inc. Expected to Reach Break-even in 2025

16:11

Jun12

Citius Pharmaceuticals Completes Registered Direct Offering

12:40

Jun10

Citius Pharmaceuticals Inc. Secures $6 Million Prepayment and Up to $9.8 Million Warrant Proceeds

11:22

Schedules & Filings

Schedules

Filings

Aug12

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -8.79 M, EPS -0.7985

May14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -10.92 M, EPS -1.2721

Feb14

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -9.768 M, EPS -1.3037

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More